Imago BioSciences, Inc.

Pioneering innovative therapies to conquer challenging diseases, enabling patients to lead longer, healthier lives.

Add To Watchlist
General Information
Company Name
Imago BioSciences, Inc.
Founded Year
2012
Location (Offices)
San Carlos, United States +1
Founders / Decision Makers
Xi Chen - Director, Analytical Chemistry Michael Arenberg - Chief Operating Officer and Chief Business Officer
Number of Employees
5
Industries
Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series C
Social Media

Imago BioSciences, Inc. - Company Profile

Imago BioSciences, established in 2012 and headquartered in Redwood City, California, is committed to advancing state-of-the-art science into innovative treatments for challenging diseases. The company's last investment of $80.00M in Series C took place on 19 November 2020. Imago BioSciences focuses on a select group of orphan diseases, translating its unique scientific insights into impactful therapies. With the support of notable investors such as Amgen Ventures, Greenspring Associates, BlackRock, Frazier Healthcare Partners, Xeraya Capital, MRL Ventures Fund, Kingdon Capital Management, Farallon Capital Management, Pharmaron, and Surveyor Capital, the company aims to pioneer innovative therapies that significantly alter the progression of diseases. Imago BioSciences' mission is to enable patients to lead longer, healthier lives.

Taxonomy: clinical development, therapeutics, innovative treatments, orphan diseases, state-of-the-art science, disease progression, transformative therapies, medical research, financial support, investors, therapeutic innovation, Redwood City, California

Funding Rounds & Investors of Imago BioSciences, Inc. (3)

View All
Funding Stage Amount No. Investors Investors Date
Series C $80.00M 10
Amgen Ventures, investor in Imago BioSciences, Inc.'s Series C round Greenspring Associates, investor in Imago BioSciences, Inc.'s Series C round BlackRock, investor in Imago BioSciences, Inc.'s Series C round Frazier Healthcare Partners, investor in Imago BioSciences, Inc.'s Series C round Xeraya Capital, investor in Imago BioSciences, Inc.'s Series C round MRL Ventures Fund, investor in Imago BioSciences, Inc.'s Series C round Kingdon Capital Management, investor in Imago BioSciences, Inc.'s Series C round
Farallon Capital Management, Pharmaron +1 		19 Nov 2020
Series B $40.00M - 21 Mar 2019
Series A $26.50M - 31 Oct 2014

Latest News of Imago BioSciences, Inc.

View All

No recent news or press coverage available for Imago BioSciences, Inc..

Similar Companies to Imago BioSciences, Inc.

View All
Leadiant Biosciences, Inc. - Similar company to Imago BioSciences, Inc.
Leadiant Biosciences, Inc. Pioneering innovative therapies for rare diseases, dedicated to enhancing patient quality of life.
Genizon BioSciences - Similar company to Imago BioSciences, Inc.
Genizon BioSciences Discovering genes and biomarkers in common diseases with innovative technology and access to the Quebec Founder Population.
NewBiotics - Similar company to Imago BioSciences, Inc.
NewBiotics Turning drug resistance into therapeutic breakthroughs, pioneering drug molecules for cancer and infectious diseases since 1997.
Avanti Biosciences, Inc. - Similar company to Imago BioSciences, Inc.
Avanti Biosciences, Inc.
Crescenta Biosciences Inc. - Similar company to Imago BioSciences, Inc.
Crescenta Biosciences Inc.
Circle Decoration Circle Decoration

Want to dive deeper into Imago BioSciences, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now